Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway. | Cell Death Dis | 2022 | 35676254 | PubTator, text mining | PubMed |
| Crosslinker-free collagen gelation for corneal regeneration. | Sci Rep | 2022 | 35650270 | PubTator, text mining | PubMed |
| Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. | Front Oncol | 2022 | 35646668 | PubTator, text mining | PubMed |
| A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs). | Pharmaceuticals (Basel) | 2022 | 35631362 | PubTator, text mining | PubMed |
| Human Umbilical Mesenchymal Stem Cell Xenografts Repair UV-Induced Photokeratitis in a Rat Model. | Biomedicines | 2022 | 35625862 | PubTator, text mining | PubMed |
3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. | Arch Pharm (Weinheim) | 2022 | 35618489 | PubTator, text mining | PubMed |
| Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling. | Nucleic Acids Res | 2022 | 35609998 | PubTator, text mining | PubMed |
| Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. | Support Care Cancer | 2022 | 35606478 | PubTator, text mining | PubMed |
| Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells. | J Radiat Res | 2022 | 35589101 | PubTator, text mining | PubMed |
| Drug-Tolerant Persister Cells in Cancer Therapy Resistance. | Cancer Res | 2022 | 35584245 | PubTator, text mining | PubMed |
| RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma. | J Transl Med | 2022 | 35568866 | PubTator, text mining | PubMed |
| Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention? | Cancers (Basel) | 2022 | 35565378 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment. | Cells | 2022 | 35563739 | PubTator, text mining | PubMed |
| Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage. | Clin Transl Med | 2022 | 35560527 | PubTator, text mining | PubMed |
| Shotgun Proteomics for the Identification and Profiling of the Tear Proteome of Keratoconus Patients. | Invest Ophthalmol Vis Sci | 2022 | 35551575 | PubTator, text mining | PubMed |
| Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing. | Stem Cells Int | 2022 | 35530414 | PubTator, text mining | PubMed |
| Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives. | Acta Pharm Sin B | 2022 | 35530147 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages. | Nat Commun | 2022 | 35508466 | PubTator, text mining | PubMed |
| Analysis of the different characteristics between omental preadipocytes and differentiated white adipocytes using bioinformatics methods. | Adipocyte | 2022 | 35499169 | PubTator, text mining | PubMed |
| The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population. | Evol Bioinform Online | 2022 | 35497687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=17